Try our Advanced Search for more refined results

KELLEY et al v. AERIE PHARMACEUTICALS, INC. et al

Track this case

Case Number:

3:15-cv-03007

Court:

New Jersey

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Anne E. Thompson

Firms

Companies

Sectors & Industries:

  1. June 20, 2016

    Shareholders Lose Suit Over Glaucoma Drug Trial

    A New Jersey federal judge on Monday threw out a proposed shareholder class action claiming Aerie Pharmaceuticals Inc. misled investors about the potential of a new glaucoma treatment, saying the investors had taken the company's statements out of context.

  2. December 01, 2015

    Glaucoma Drug Co. Says Investor Suit 'Makes No Sense'

    Aerie Pharmaceuticals Inc. on Monday fired back at a putative class action brought by investors who say the company misled them into thinking its top drug would perform better in clinical trials, telling a New Jersey federal court that the suit is based on "unfounded speculation" and "makes no sense."

  3. July 28, 2015

    Robbins Geller Named Lead Counsel In Glaucoma Drug Row

    A New Jersey federal judge on Monday appointed Robbins Geller Rudman & Dowd LLP as lead counsel in a proposed class action filed against glaucoma drug company Aerie Pharmaceuticals Inc. by investors that say that the company misled them into thinking its top drug would perform better in clinical trials.

  4. April 30, 2015

    Glaucoma Drug Co. Hit With Class Action After Trial Tanks

    Glaucoma drug company Aerie Pharmaceuticals was slapped with a proposed class action Wednesday by investors who say the company misled them into believing its lead drug would perform better in clinical trials.